Literature DB >> 21928097

HIV transmission rate modeling: a primer, review, and extension.

Steven D Pinkerton1.   

Abstract

Several mathematical modeling studies based on the concept of "HIV transmission rates" have recently appeared in the literature. The transmission rate for a particular group of HIV-infected persons is defined as the mean number of secondary infections per member of the group per unit time. This article reviews the fundamental principles and mathematics of transmission rate models; explicates the relationship between these models, Bernoullian models of HIV transmission, and mathematical models based on the concept of the "reproductive rate of infection"; describes an extension of existing transmission rate models to better incorporate the positive impact of HIV treatment; and discusses the limitations of the transmission rate modeling approach. Results from the extended transmission rate model indicate that approximately 51.6% of new sexually-transmitted infections in the US are due to the transmission risk behaviors of infected persons who are unaware of their infection, including 10.9% due to persons in the acute phase of HIV infection. Findings from this study suggest that significant reductions in HIV incidence likely will require a combination of increased antibody testing, enhanced early detection of acute HIV infection, appropriate medical care and antiretroviral medicine adherence counseling, and behavioral risk reduction interventions.

Entities:  

Mesh:

Year:  2012        PMID: 21928097      PMCID: PMC4103007          DOI: 10.1007/s10461-011-0042-8

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  26 in total

1.  Potential and limitations of a 'test and treat' strategy as HIV prevention in the United States.

Authors:  D R Holtgrave
Journal:  Int J Clin Pract       Date:  2010-05       Impact factor: 2.503

2.  How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission?

Authors:  Steven D Pinkerton
Journal:  AIDS       Date:  2007-07-31       Impact factor: 4.177

3.  Infections prevented by increasing HIV serostatus awareness in the United States, 2001 to 2004.

Authors:  Steven David Pinkerton; David Robert Holtgrave; Carol Lynne Galletly
Journal:  J Acquir Immune Defic Syndr       Date:  2008-03-01       Impact factor: 3.731

4.  Universal voluntary testing and treatment for prevention of HIV transmission.

Authors:  Carl W Dieffenbach; Anthony S Fauci
Journal:  JAMA       Date:  2009-06-10       Impact factor: 56.272

5.  Updated annual HIV transmission rates in the United States, 1977-2006.

Authors:  David Holtgrave; H Irene Hall; Philip H Rhodes; Richard Wolitski
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

6.  Sexually acquired HIV infections in the United States due to acute-phase HIV transmission: an update.

Authors:  Vimalanand S Prabhu; Angela B Hutchinson; Paul G Farnham; Stephanie L Sansom
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

7.  Is the elimination of HIV infection within reach in the United States? Lessons from an epidemiologic transmission model.

Authors:  David R Holtgrave
Journal:  Public Health Rep       Date:  2010 May-Jun       Impact factor: 2.792

8.  Can increasing awareness of HIV seropositivity reduce infections by 50% in the United States?

Authors:  David R Holtgrave; Steven D Pinkerton
Journal:  J Acquir Immune Defic Syndr       Date:  2007-03-01       Impact factor: 3.731

9.  Estimation of HIV incidence in the United States.

Authors:  H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

10.  Changing epidemiology of HIV/AIDS in the United States: implications for enhancing and promoting HIV testing strategies.

Authors:  Kevin A Fenton
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

View more
  9 in total

Review 1.  Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review.

Authors:  Xiao Zang; Emanuel Krebs; Linwei Wang; Brandon D L Marshall; Reuben Granich; Bruce R Schackman; Julio S G Montaner; Bohdan Nosyk
Journal:  Pharmacoeconomics       Date:  2019-10       Impact factor: 4.981

2.  Is the US AIDS drug assistance program cost-effective?

Authors:  Steven D Pinkerton; Jennifer Kibicho; Carol L Galletly
Journal:  AIDS Behav       Date:  2013-01

3.  Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care.

Authors:  Evelyn Byrd Quinlivan; Shilpa N Patel; Catherine A Grodensky; Carol E Golin; Hsiao-Chuan Tien; Marcia M Hobbs
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

4.  The efficacy of serostatus disclosure for HIV Transmission risk reduction.

Authors:  Ann A O'Connell; Sandra J Reed; Julianne A Serovich
Journal:  AIDS Behav       Date:  2015-02

5.  Cost analysis of enhancing linkages to HIV care following jail: a cost-effective intervention.

Authors:  Anne C Spaulding; Steven D Pinkerton; Hillary Superak; Marc J Cunningham; Stephen Resch; Alison O Jordan; Zhou Yang
Journal:  AIDS Behav       Date:  2013-10

6.  Posterior Estimates of Dynamic Constants in HIV Transmission Modeling.

Authors:  Yingqing Chen; Renee Dale; Hongyu He; Quoc-Anh T Le
Journal:  Comput Math Methods Med       Date:  2017-11-07       Impact factor: 2.238

7.  Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIV.

Authors:  Thomas J Dilworth; Pamela W Klein; Renée-Claude Mercier; Matthew E Borrego; Bernadette Jakeman; Steven D Pinkerton
Journal:  J Manag Care Spec Pharm       Date:  2018-02

8.  Assessment of the Cost-Effectiveness of a Brief Video Intervention for Sexually Transmitted Disease Prevention.

Authors:  Austin M Williams; Thomas L Gift; Lydia N O'Donnell; Cornelis A Rietmeijer; C Kevin Malotte; Andrew D Margolis; Lee Warner
Journal:  Sex Transm Dis       Date:  2020-02       Impact factor: 3.868

9.  Estimating epidemiological parameters of a stochastic differential model of HIV dynamics using hierarchical Bayesian statistics.

Authors:  Renee Dale; BeiBei Guo
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.